Back
Corbus Pharmaceuticals Holdings Quote, Financials, Valuation and Earnings
Sponsored
CRBP
Sponsored
Potential crash warning signs flashing again on my charts
Here's my #1 indicator to try out now.
Sell
43
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
52.68
Seasonality Move:
-9.84%
7 Day Trial
ALL ACCESS PASS
$
7
1-day winners in this choppy market
Get the 1-day winners strategy here.Corbus Pharmaceuticals Holdings Price Quote
$52.68
+2.64 (+5.28%)
(Updated: September 9, 2024 at 6:55 PM ET)
Corbus Pharmaceuticals Holdings Key Stats
Sell
43
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Day range:
$48.45 - $52.00
52-week range:
$3.03 - $61.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
229.19
P/B ratio:
4.8%
Volume:
250K
Avg. volume:
274.1K
1-year change:
623.12%
Market cap:
$602.7M
Revenue:
$0
EPS:
$-5.79
How Much Does Corbus Pharmaceuticals Holdings Make?
Data Unavailable
Is Corbus Pharmaceuticals Holdings Growing As A Company?
Data Unavailable
Corbus Pharmaceuticals Holdings Stock Price Performance
-
Did Corbus Pharmaceuticals Holdings Stock Go Up Last Month?
Corbus Pharmaceuticals Holdings share price went down by -5.48% last month -
Did CRBP's Share Price Rise Over The Last Year?
CRBP share price rose by 623.12% over the past 1 year
What Is Corbus Pharmaceuticals Holdings 52-Week High & Low?
-
What Is Corbus Pharmaceuticals Holdings’s 52-Week High Share Price?
Corbus Pharmaceuticals Holdings has traded as high as $61.90 over the past 52 weeks -
What Is Corbus Pharmaceuticals Holdings’s 52-Week Low Share Price?
Corbus Pharmaceuticals Holdings has traded as low as $3.03 over the past 52 weeks
Corbus Pharmaceuticals Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Corbus Pharmaceuticals Holdings?
-
How Much Debt Does Corbus Pharmaceuticals Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Corbus Pharmaceuticals Holdings Have?
Cash and short term investments quarterly total is $147M -
What Is Corbus Pharmaceuticals Holdings’s Book Value Per Share?
Book value per share is 10.92
Is Corbus Pharmaceuticals Holdings Cash Flow Positive?
-
What Is CRBP Cash Flow From Operations?
Cash flow from operations (TTM) is -$30.1M -
What Is Corbus Pharmaceuticals Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $138.8M -
What Is Corbus Pharmaceuticals Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$93.4M
Corbus Pharmaceuticals Holdings Return On Invested Capital
Data Unavailable
Corbus Pharmaceuticals Holdings Earnings Date & Stock Price
-
What Is Corbus Pharmaceuticals Holdings's Stock Price Today?
A single share of CRBP can be purchased today for 50.04 -
What Is Corbus Pharmaceuticals Holdings’s Stock Symbol?
Corbus Pharmaceuticals Holdings trades on the nasdaq under the ticker symbol: CRBP -
When Is Corbus Pharmaceuticals Holdings’s Next Earnings Date?
The next quarterly earnings date for Corbus Pharmaceuticals Holdings is scheduled on November 7, 2024 -
When Is CRBP's next ex-dividend date?
Corbus Pharmaceuticals Holdings's next ex-dividend date is May 30, 2020 -
How To Buy Corbus Pharmaceuticals Holdings Stock?
You can buy Corbus Pharmaceuticals Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Corbus Pharmaceuticals Holdings Competitors
-
Who Are Corbus Pharmaceuticals Holdings's Competitors?
Below is a list of companies who compete with Corbus Pharmaceuticals Holdings or are related in some way:
Corbus Pharmaceuticals Holdings Dividend Yield
-
What Is CRBP Dividend Yield?
Corbus Pharmaceuticals Holdings’s dividend yield currently is 0% -
What Is Corbus Pharmaceuticals Holdings’s Payout Ratio?
Corbus Pharmaceuticals Holdings’s payout ratio is 0% -
When Did Corbus Pharmaceuticals Holdings Last Pay A Dividend?
The latest dividend pay date is September 10, 2024 -
What Is Corbus Pharmaceuticals Holdings’s Dividend Per Share?
Corbus Pharmaceuticals Holdings pays a dividend of $0.00 per share
Corbus Pharmaceuticals Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 24.26% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 81.43 |
Upside from Last Price: | 62.73% |